Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

T cell activation starts with formation of second messengers that release Ca2+ from the endoplasmic reticulum (ER) and thereby activate store-operated Ca2+ entry (SOCE), one of the essential signals for T cell activation. Recently, the steroidal 2-methoxyestradiol was shown to inhibit nuclear translocation of the nuclear factor of activated T cells (NFAT). We therefore investigated 2-methoxyestradiol for inhibition of Ca2+ entry in T cells, screened a library of 2-methoxyestradiol analogues, and characterized the derivative 2-ethyl-3-sulfamoyloxy-17β-cyanomethylestra-1,3,5(10)-triene (STX564) as a novel, potent and specific SOCE inhibitor. STX564 inhibits Ca2+ entry via SOCE without affecting other ion channels and pumps involved in Ca2+ signaling in T cells. Downstream effects such as cytokine expression and cell proliferation were also inhibited by both 2-methoxyestradiol and STX564, which has potential as a new chemical biology tool.

More information Original publication

DOI

10.1016/j.bbamcr.2021.118988

Type

Journal article

Publication Date

2021-05-01T00:00:00+00:00

Volume

1868

Keywords

Ca(2+) signaling, ORAI inhibitor, Store-operated Ca(2+) entry, T cell activation, 2-Methoxyestradiol, Animals, Calcium, Calcium Signaling, Cell Line, Cell Nucleus, Estrenes, Gene Expression Regulation, Humans, Jurkat Cells, Lymphocyte Activation, NFATC Transcription Factors, Protein Transport, Rats, T-Lymphocytes